Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125962491 | 12596249 | 1 | I | 20160718 | 20160727 | 20160727 | EXP | ZA-STRIDES ARCOLAB LIMITED-2016SP010406 | STRIDES | 0.00 | Y | 0.00000 | 20160726 | OT | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125962491 | 12596249 | 1 | PS | NEVIRAPINE. | NEVIRAPINE | 1 | UNK | U | U | 78195 | |||||||||
| 125962491 | 12596249 | 2 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | U | U | 78195 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125962491 | 12596249 | 1 | HIV infection |
| 125962491 | 12596249 | 2 | Prophylaxis against HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125962491 | 12596249 | HO |
| 125962491 | 12596249 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125962491 | 12596249 | Corneal lesion | |
| 125962491 | 12596249 | Exposure during pregnancy | |
| 125962491 | 12596249 | Genital lesion | |
| 125962491 | 12596249 | Oral disorder | |
| 125962491 | 12596249 | Pre-eclampsia | |
| 125962491 | 12596249 | Premature delivery | |
| 125962491 | 12596249 | Stevens-Johnson syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |